thoughts on these estimates, before EPS results? NASDAQ:CVGW, NYSE:REVG, NASDAQ:LMFA, NASDAQ:ADXS

0
337

CALAVO GROWERS (NASDAQ:CVGW) EARNINGS INFORMATION (NASDAQ:CVGW)

Calavo Growers last released its quarterly earnings results on September 8th, 2020. The reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.01. The firm earned $270.40 million during the quarter, compared to the consensus estimate of $325.37 million. Its revenue was down 24.7% on a year-over-year basis. Calavo Growers has generated $3.02 earnings per share over the last year. Calavo Growers has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, December 17th, 2020 based off prior year’s report dates.

HOW HAS CALAVO GROWERS’ STOCK PRICE BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NASDAQ:CVGW)

Calavo Growers’ stock was trading at $53.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CVGW shares have increased by 19.9% and is now trading at $63.58.

REV GROUP (NYSE:REVG) EARNINGS INFORMATION (NYSE:REVG)

Rev Group last issued its earnings results on September 9th, 2020. The reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.09. The business had revenue of $582.20 million for the quarter, compared to analysts’ expectations of $551.74 million. Its revenue for the quarter was down 5.6% compared to the same quarter last year. Rev Group has generated $0.40 earnings per share over the last year. Rev Group has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, December 16th, 2020 based off prior year’s report dates.

HOW HAS REV GROUP’S STOCK BEEN IMPACTED BY CORONAVIRUS? (NYSE:REVG)

Rev Group’s stock was trading at $6.34 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, REVG stock has increased by 21.5% and is now trading at $7.70.

LM FUNDING AMERICA EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:LMFA)

HOW HAS LM FUNDING AMERICA’S STOCK PRICE BEEN IMPACTED BY CORONAVIRUS (COVID-19)? (NASDAQ:LMFA)

LM Funding America’s stock was trading at $0.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LMFA stock has decreased by 14.3% and is now trading at $0.60.

ADVAXIS (NASDAQ:ADXS) EARNINGS INFORMATION (NASDAQ:ADXS)

Advaxis last posted its earnings data on September 10th, 2020. The biotechnology company reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.06. Advaxis has generated $0.00 earnings per share over the last year. Advaxis has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, December 18th, 2020 based off prior year’s report dates.

HOW HAS ADVAXIS’ STOCK PRICE BEEN IMPACTED BY CORONAVIRUS? (NASDAQ:ADXS)

Advaxis’ stock was trading at $0.6666 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ADXS shares have decreased by 33.9% and is now trading at $0.4404.